Covid-19: India's Serum Institute applies for full approval of Covishield vaccine

Serum Institute Of India has applied to the country's drug regulator and the health ministry for full market authorisation of its Covid-19 vaccine, Covishield, the company's chief executive said in a tweet on Friday.

Serum Institute produces AstraZeneca's Covid-19 vaccine under the brand name Covishield.

• Covid: Indian vaccine maker working on 'more effective' booster shot against Omicron